Elevated Cyclins and Cyclin-dependent Kinase Activity in the Rhabdomyosarcoma Cell Line RD

Cancer Research

Volumn 58, Issue 9, 1998, Pages 2042-2049

  Knudsen, Erik S ^a   Pazzagli, Claudia ^a   Born, Teresa L ^a   Bertolaet, Bonnie L ^a   Knudsen, Karen E ^a   Arden, Karen C ^a   Henry, Robert R ^a   Feramisco, James R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; MYOD PROTEIN; RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIUM; DNA SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RHABDOMYOSARCOMA;

CELL CYCLE; CELL DIFFERENTIATION; CULTURE MEDIA, CONDITIONED; CYCLIN-DEPENDENT KINASES; CYCLINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MUSCLE NEOPLASMS; MYOD PROTEIN; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; RHABDOMYOSARCOMA; TUMOR CELLS, CULTURED;

EID: 0032080649     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Pappo, A. S., Shapiro, D. N., Crist, W. M., and Maurer, H. M. Biology and therapy of pediatric rhabdomyosarcoma. J. Clin. Oncol., 13: 2123-2139, 1995.
2. Parhamm D. M. The molecular biology of childhood rhabdomyosarcoma. Semin. Diagn. Pathol., 11: 39-46, 1994.
3. Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., III, Emanuel, B. S., Rovera, G., and Barr, F. G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet., 5: 230-235, 1993.
4. Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., and Emanuel, B. S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet., 3: 113-117, 1993.
5. Epstein, J. A., and Shapiro, D. N. Pax3 inhibits myogenic differentiation of myoblast cells. J. Biol. Chem., 270: 11719-11722, 1995.
6. Scheidler, S., Fredericks, W. J., Rauscher, F. J., III, Barr, F. G., and Vogt, P. K. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Proc. Natl. Acad. Sci. USA, 93: 9805-9809, 1996.
7. Koufos, A., Hansen, M. F., Copeland, N. G., Jenkins, N. A., Lampkin, B. C., and Cavenee, W. K. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature (Lond.), 316: 330-334, 1985.
8. Loh, W. E., Jr., Scrable, H. J., Livanos, E., Arboleda, M. J., Cavenee, W. K., Oshimura, M., and Weissman, B. E. Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA, 89: 1755-1759, 1992.
9. Lassar, A. B., Skapek, S. X., and Novitch, B: Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol., 6: 788-794, 1994.
10. Li, L., and Olson, E. N. Regulation of muscle cell growth and differentiation by the MyoD family of helix-loop-helix proteins. Adv. Cancer Res., 58: 95-119, 1992.
11. Alema, S., and Tato, F. Oncogenes and muscle differentiation: multiple mechanisms of interference. Semin. Cancer Biol., 5: 147-156, 1994.
12. 2 phases of the cell cycle. J. Cell Biol., 135: 441-456, 1996.
13. Franklin, D. S., and Xiong, Y. Induction of p181NK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell, 7: 1587-1599, 1996.
14. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267, 1018-1021, 1995.
15. Skapek, S. X., Rhee, J., Kim, P. S., Novitch, B. G., and Lassar, A. B. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol., 16: 7043-7053, 1996.
16. Rao, S. S., Chu, C., and Kohtz, D. S. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol., 14: 5259-5267, 1994.
17. Skapek, S. X., Rhee, J., Spicer, D. B., and Lassar, A. B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (Washington DC), 267: 1022-1024, 1995.
18. Sidle, A., Palaty, C., Dirks, P., Wiggan, O., Kiess, M., Gill, R. M., Wong, A. K., and Hamel, P. A. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit. Rev. Biochem. Mol. Biol., 31: 237-271, 1996.
19. Beijersbergen, R. L., and Bernards, R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta, 1287: 103-120, 1996.
20. 1-S-regulatory genes. Mol. Cell. Biol., 15: 4215-4224, 1995.
21. Schneider, J. W., Gu, W., Zhu, L., Mahdavi, V., and Nadal-Ginard, B. Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science (Washington DC), 264: 1467-1471, 1994.
22. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal-Ginard, B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell, 72: 309-324, 1993.
23. Thorbum, A. M., Walton, P. A., and Feramisco, J. R. MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein. Mol. Biol. Cell, 4: 705-713, 1993.
24. Henry, R. R., Ciaraldi, T. P., Abrams-Carter, L., Mudaliar, S., Park, K. S., and Nikoulina, S. E. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects: biochemical and molecular mechanisms. J. Clin. Invest., 98: 1231-1236, 1996.
25. Knudsen, E. S., and Wang, J. Y. Dual mechanisms for the inhibition of E2F binding to RB by cyclin dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol., 17: 5771-5783, 1997.
26. Knudsen, K. E., Knudsen, E. S., Wang, J. Y., and Subramani, S. p34cdc2 kinase activity is maintained upon activation of the replication checkpoint in Schizosacchormyces pombe. Proc. Natl. Acad. Sci. USA, 93: 8278-8283, 1996.
27. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11: 847-862, 1997.
28. Welch, P. J., and Wang, J. Y. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell, 75: 779-790, 1993.
29. 1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc. Natl. Acad. Sci. USA, 90: 11034-11038, 1993.
30. Tapscott, S. J., Thayer, M. J., and Weintraub, H. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science (Washington DC), 259: 1450-1453, 1993.
31. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
32. Iolascon, A., Faienza, M. F., Coppola, B., Rosolen, A., Basso, G., Della Ragione, F., and Schettini, F. Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma. Genes Chromosomes Cancer, 15: 217-222, 1996.
33. Okamoto, A., Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W. P., Forrester, K., Gerwin, B., Serrano, M., Beach, D. H., and Harris, C. C. Mutations and altered expression of p16INK4 in human cancer. Proc. Natl. Acad. Sci. USA, 91: 11045-11049, 1994.
34. Zhang, S. Y., Klein-Szanto, A. J., Sauter, E. R., Shafarenko, M., Mitsunaga, S., Nobori, T., Carson, D. A., Ridge, J. A., and Goodrow, T. L. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54: 5050-5053, 1994.
35. Yeager, T., Stadler, W., Belair, C., Puthenveettil, J., Olopade, O., and Reznikoff, C. Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res., 55: 493-497, 1995.
36. Shapiro, G. I., Edwards, C. D., Kobzik, L., Godleski, J., Richards, W., Sugarbaker, D. J., and Rollins, B. J. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res., 55: 505-509, 1995.
37. Parry, D., Bates, S., Mann, D. J., and Peters, G. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J., 14: 503-511, 1995.
38. Bouché, M., Zappelli, F., Polimeni, M., Adamo, S., Wetsel, W. C., Senni, M. I., and Molinaro, M. Rapid activation and down-regulation of protein kinase C α in TPA-induced differentiation of human rhabdomyosarcoma cells. Cell Growth Differ., 6: 845-852, 1995.
39. Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A.,. G., Bossi, G., Cimino, L., Crescenzi, M., and Sacchi, A. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol., 134: 193-204, 1996.
40. Germani, A., Fusco, C., Martinotti, S., Musaro, A., Molinaro, M., and Zani, B. M. TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53. Biochem. Biophys. Res. Commun., 202: 17-24, 1995.
41. Eckner, R., Yao, T-P., Oldread, E., and Livingston, D. M. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev., 10: 2478-2490, 1996.
42. Puri, P. L., Avantaggiati, M. L., Balsano, C., Sang, N., Graessmann, A., Giordano, A., and Levrero, M. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J., 16: 369-383, 1997.